Skip to content

Kura Oncology KURA Increase Decrease In Operating Lease Right Of Use Assets And Other Noncurrent Assets

Increase Decrease In Operating Lease Right Of Use Assets And Other Noncurrent Assets at other companies

SkyWest logo
SkyWestSKYW
-$1.45M-676%
Sana Biotechnology logo
Sana BiotechnologySANA
$1.5M+268%
Advance Auto Parts logo
Advance Auto PartsAAP
-$24M+52.0%
EverQuote logo
EverQuoteEVER
-$298K-11.6%
Impinj, Inc. logo
Impinj, Inc.PI
-$390K+40.3%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$300K-41.7%

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$919.7M+81.6%
Enterprise value$904.89M+90.7%
P/S12.8×+3.5×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept kura:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOtherNoncurrentAssets.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's increase decrease in operating lease right of use assets and other noncurrent assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kura Oncology's increase decrease in operating lease right of use assets and other noncurrent assets?
Kura Oncology (KURA) reported increase decrease in operating lease right of use assets and other noncurrent assets of -$689K in Q1 2026.
How has Kura Oncology's increase decrease in operating lease right of use assets and other noncurrent assets changed year-over-year?
Kura Oncology's increase decrease in operating lease right of use assets and other noncurrent assets decreased by 139.3% year-over-year, from $1.75M to -$689K.
What is the long-term trend for Kura Oncology's increase decrease in operating lease right of use assets and other noncurrent assets?
Over 3 years (2021 to 2025), Kura Oncology's increase decrease in operating lease right of use assets and other noncurrent assets has grown at a 168.4% compound annual growth rate (CAGR), from $329K to $6.36M.
What does increase decrease in operating lease right of use assets and other noncurrent assets mean?
This metric captures the net change in the balance sheet value of right-of-use assets and related non-current assets associated with operating leases. It reflects the non-cash impact of lease accounting standards on operating cash flow, specifically accounting for the amortization of the asset and changes in lease obligations. Monitoring this helps analysts understand how lease-related accounting adjustments affect the company's reported operating cash position.